application): The education and information transfer core provides professional and nonprofessional training and an outreach program to publicize the ADRC, improve clinical and research skills related to AD, and foster interest in AD and related disorders.
Four aims are carried forward from the original funding period to the current application. These include: 1. Establishment, provision, and refinement of professional educational programs on AD and related disorders; 2. Establishment, provision, and refinement of public educational programs on AD and related disorders; 3. Continued dissemination of training materials on AD and related disorders; and 4. Implementation and dissemination of training programs to under served populations. For each aim, the applicants will continue with the programs and plans they have successfully implemented in the past. In addition, they will launch a new initiative under each aim. Throughout each of these activities, they will continue to work collaboratively with other ADRC cores and projects, UW Aging and Alzheimer associations, and ethnic-based organizations and groups to ensure that their activities reach the broadest audiences and provide specialized education where needed. The new initiatives for each aim are: 1.
(aim 1) Evaluation of professional continuing education programs, 2.
(aim 2) Adaptation of current educational materials to web-based technology, 3.
(aim 3) Dissemination of educational materials to staff and families of patients in assisted living and board and care homes, and 4.
(aim 4) Extension of outreach to the Blackfoot Indian Nation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005136-19
Application #
6593355
Study Section
Project Start
2002-06-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Turk, Katherine W; Flanagan, Margaret E; Josephson, Samuel et al. (2018) Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra. Cerebellum 17:143-151
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Bharadwaj, Rajnish; Cimino, Patrick J; Flanagan, Margaret E et al. (2018) Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. Histopathology 72:433-440
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894

Showing the most recent 10 out of 753 publications